About me
Magdalena Harrington is a subject matter expert in clinical outcomes assessment (COA) research with over 15 years of experience in delivering health outcomes strategies that demonstrate clinical and economic value of new medicines. She has extensive training in qualitative and quantitative instrument development methods. Magdalena joined Pfizer in 2018 and is leading Patient-Centered Outcomes Assessment (PCOA) team of COA scientists, designing and implementing COA strategies for successful registration and access across the enterprise. Before joining Pfizer, Magdalena developed and implemented patient-centered COA strategies at Shire (now Takeda).
